These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 16431104)

  • 1. High-throughput techniques in breast cancer: a clinical perspective.
    Espinosa E; Redondo A; Vara JA; Zamora P; Casado E; Cejas P; Barón MG
    Eur J Cancer; 2006 Mar; 42(5):598-607. PubMed ID: 16431104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical proteomics in breast cancer: a review.
    Gast MC; Schellens JH; Beijnen JH
    Breast Cancer Res Treat; 2009 Jul; 116(1):17-29. PubMed ID: 19082706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of gene-expression profiling and its clinical use in breast cancer.
    Stadler ZK; Come SE
    Crit Rev Oncol Hematol; 2009 Jan; 69(1):1-11. PubMed ID: 18614375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of international treatment guidelines and prognostic tests for the treatment of early breast cancer.
    Muñoz M; Estévez LG; Alvarez I; Fernández Y; Margelí M; Tusquets I; Seguí MA; Lluch A
    Cancer Treat Rev; 2008 Dec; 34(8):701-9. PubMed ID: 18922644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Designing the future shape of breast cancer diagnosis, prognosis and treatment.
    Dowsett M
    Breast Cancer Res Treat; 2004; 87 Suppl 1():S27-9. PubMed ID: 15597218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving decision-making in early breast cancer: who to treat and how?
    Llombart-Cussac A
    Breast Cancer Res Treat; 2008 Dec; 112 Suppl 1():15-24. PubMed ID: 19082929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-throughput genomic technology in research and clinical management of breast cancer. Plasma-based proteomics in early detection and therapy.
    Davis MA; Hanash S
    Breast Cancer Res; 2006; 8(6):217. PubMed ID: 17184556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implications of applied research for prognosis and therapy of breast cancer.
    Barginear MF; Bradley T; Shapira I; Budman DR
    Crit Rev Oncol Hematol; 2008 Mar; 65(3):223-34. PubMed ID: 18243013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An updated catalog of prostate cancer predictive tools.
    Shariat SF; Karakiewicz PI; Roehrborn CG; Kattan MW
    Cancer; 2008 Dec; 113(11):3075-99. PubMed ID: 18823041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current status of prognostic profiling in breast cancer.
    Pusztai L
    Oncologist; 2008 Apr; 13(4):350-60. PubMed ID: 18448548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple biomarkers in molecular oncology. II. Molecular diagnostics applications in breast cancer management.
    Malinowski DP
    Expert Rev Mol Diagn; 2007 May; 7(3):269-80. PubMed ID: 17489734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant chemotherapy for early-stage breast cancer.
    McArthur HL; Hudis CA
    Hematol Oncol Clin North Am; 2007 Apr; 21(2):207-22. PubMed ID: 17512445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomics, morphoproteomics, saliva and breast cancer: an emerging approach to guide the delivery of individualised thermal therapy, thermochemotherapy and monitor therapy response.
    Streckfus CF; Brown RE; Bull JM
    Int J Hyperthermia; 2010; 26(7):649-61. PubMed ID: 20849260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The use of breast cancer subtype classification to predict local and distant recurrence. A review].
    Belkacémi Y; Penault-Llorca F; Gligorov J; Azria D
    Cancer Radiother; 2008 Nov; 12(6-7):577-83. PubMed ID: 18824383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomics: new technologies and clinical applications.
    Latterich M; Abramovitz M; Leyland-Jones B
    Eur J Cancer; 2008 Dec; 44(18):2737-41. PubMed ID: 18977654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999.
    Mariotto AB; Feuer EJ; Harlan LC; Abrams J
    J Natl Cancer Inst Monogr; 2006; (36):7-15. PubMed ID: 17032888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer in the elderly.
    Crivellari D; Aapro M; Leonard R; von Minckwitz G; Brain E; Goldhirsch A; Veronesi A; Muss H
    J Clin Oncol; 2007 May; 25(14):1882-90. PubMed ID: 17488987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New molecular classifications of breast cancer.
    Cianfrocca M; Gradishar W
    CA Cancer J Clin; 2009; 59(5):303-13. PubMed ID: 19729680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Predicting response to therapy in breast cancer].
    Strunz K; Deissler H; Kreienberg R; Sauer G
    Gynakol Geburtshilfliche Rundsch; 2008; 48(3):113-7. PubMed ID: 18566527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.